Status:
UNKNOWN
Evaluation of Glycocalyx in Major Abdominal and Thoracic Surgery
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Major Elective Abdominal and Thoracic Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Background: The glycocalyx is a fundamental component of the endothelial barrier and alterations at this level have been shown to exacerbate the inflammatory response in the microcirculation. Its deg...
Eligibility Criteria
Inclusion
- Patients older than 18 years old
- Patients that are scheduled to major abdominal and thoracic elective surgery in Universtity Hospital Vall d´ Hebrón.
- Patients ASA I, II and III.
- Patients that after the intervention have their recovering in the Surgical ICU
Exclusion
- Patients ASA IV and V.
- Patients that are hospitilized previous to the surgery.
- Patients that undergo emergent surgery.
- Patients with Chronic or Acute Renal Failure previous to the surgery.
- Patients with past medical history of autoinmune disseases.
- Patients with an active infection previous to the surgery.
- Patients in treatment with steroids previous to the surgery
Key Trial Info
Start Date :
February 2 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04900779
Start Date
February 2 2021
End Date
May 31 2022
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari Vall d´Hebron
Barcelona, Spain